217 related articles for article (PubMed ID: 17038479)
1. Use of cell permeable NBD peptides for suppression of inflammation.
Strickland I; Ghosh S
Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii75-82. PubMed ID: 17038479
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide.
Davé SH; Tilstra JS; Matsuoka K; Li F; Karrasch T; Uno JK; Sepulveda AR; Jobin C; Baldwin AS; Robbins PD; Plevy SE
J Immunol; 2007 Dec; 179(11):7852-9. PubMed ID: 18025231
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides.
Baima ET; Guzova JA; Mathialagan S; Nagiec EE; Hardy MM; Song LR; Bonar SL; Weinberg RA; Selness SR; Woodard SS; Chrencik J; Hood WF; Schindler JF; Kishore N; Mbalaviele G
J Biol Chem; 2010 Apr; 285(18):13498-506. PubMed ID: 20167598
[TBL] [Abstract][Full Text] [Related]
4. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
[TBL] [Abstract][Full Text] [Related]
5. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.
Dai S; Hirayama T; Abbas S; Abu-Amer Y
J Biol Chem; 2004 Sep; 279(36):37219-22. PubMed ID: 15252035
[TBL] [Abstract][Full Text] [Related]
6. Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation.
Tas SW; Vervoordeldonk MJ; Hajji N; May MJ; Ghosh S; Tak PP
Arthritis Res Ther; 2006; 8(4):R86. PubMed ID: 16684367
[TBL] [Abstract][Full Text] [Related]
7. NEMO-binding domain peptides alleviate perihematomal inflammation injury after experimental intracerebral hemorrhage.
Luo Q; Li D; Bao B; Wan X; Pan B; Tu J; Wang H; Ouyang Y; Chen Z; Yin X
Neuroscience; 2019 Jun; 409():43-57. PubMed ID: 31047976
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex.
May MJ; D'Acquisto F; Madge LA; Glöckner J; Pober JS; Ghosh S
Science; 2000 Sep; 289(5484):1550-4. PubMed ID: 10968790
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
10. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
[TBL] [Abstract][Full Text] [Related]
11. The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation.
Grassia G; Maddaluno M; Musilli C; De Stefano D; Carnuccio R; Di Lauro MV; Parratt CA; Kennedy S; Di Meglio P; Ianaro A; Maffia P; Parenti A; Ialenti A
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2458-66. PubMed ID: 20930169
[TBL] [Abstract][Full Text] [Related]
12. A Peptide Derived from IKK-Interacting Protein Attenuates NF-κB Activation and Inflammation.
Liu H; Yan Z; Zhao Y; Ma X; Zhang H; Wang X; Zhuang W; Zheng Y; Liu B; Zhang L; Gao C
J Immunol; 2021 Sep; 207(6):1652-1661. PubMed ID: 34426543
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology.
Reay DP; Yang M; Watchko JF; Daood M; O'Day TL; Rehman KK; Guttridge DC; Robbins PD; Clemens PR
Neurobiol Dis; 2011 Sep; 43(3):598-608. PubMed ID: 21624467
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting proinflammatory NF-kappaB signaling using cell-penetrating NEMO binding domain peptides.
Madge LA; May MJ
Methods Mol Biol; 2009; 512():209-32. PubMed ID: 19347279
[TBL] [Abstract][Full Text] [Related]
15. NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.
Solt LA; Madge LA; May MJ
J Biol Chem; 2009 Oct; 284(40):27596-608. PubMed ID: 19666475
[TBL] [Abstract][Full Text] [Related]
16. NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.
Gaurnier-Hausser A; Patel R; Baldwin AS; May MJ; Mason NJ
Clin Cancer Res; 2011 Jul; 17(14):4661-71. PubMed ID: 21610150
[TBL] [Abstract][Full Text] [Related]
17. NBD peptides protect against ischemia reperfusion after orthotopic liver transplantation in rats.
Cheng MX; Gong JP; Chen Y; Liu ZJ; Tu B; Liu CA
J Surg Res; 2012 Aug; 176(2):666-71. PubMed ID: 22381173
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis.
Shibata W; Maeda S; Hikiba Y; Yanai A; Ohmae T; Sakamoto K; Nakagawa H; Ogura K; Omata M
J Immunol; 2007 Sep; 179(5):2681-5. PubMed ID: 17709478
[TBL] [Abstract][Full Text] [Related]
19. Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli.
Berchtold CM; Wu ZH; Huang TT; Miyamoto S
Mol Cell Biol; 2007 Jan; 27(2):497-509. PubMed ID: 17074802
[TBL] [Abstract][Full Text] [Related]
20. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
